Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin-Like Growth Factor I | 6 | 2014 | 59 | 1.900 |
Why?
|
| Fracture Healing | 6 | 2020 | 32 | 1.790 |
Why?
|
| Fractures, Bone | 5 | 2022 | 75 | 1.720 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 6 | 2015 | 31 | 1.290 |
Why?
|
| Gastric Bypass | 7 | 2020 | 69 | 1.250 |
Why?
|
| Joints | 4 | 2019 | 69 | 1.230 |
Why?
|
| Animals | 21 | 2022 | 3681 | 1.060 |
Why?
|
| Signal Transduction | 7 | 2022 | 455 | 0.980 |
Why?
|
| Obesity, Morbid | 5 | 2020 | 105 | 0.960 |
Why?
|
| Receptors, Transforming Growth Factor beta | 3 | 2013 | 5 | 0.870 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2020 | 165 | 0.830 |
Why?
|
| Receptors, Chemokine | 1 | 2022 | 10 | 0.800 |
Why?
|
| Chondrocytes | 5 | 2019 | 155 | 0.770 |
Why?
|
| Mice | 12 | 2019 | 1449 | 0.760 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2014 | 17 | 0.750 |
Why?
|
| Weight Loss | 3 | 2020 | 127 | 0.720 |
Why?
|
| Cell Differentiation | 7 | 2020 | 137 | 0.650 |
Why?
|
| Homeostasis | 2 | 2022 | 70 | 0.640 |
Why?
|
| Bony Callus | 5 | 2022 | 6 | 0.640 |
Why?
|
| Protein Precursors | 1 | 2019 | 20 | 0.640 |
Why?
|
| Bone Diseases | 2 | 2010 | 24 | 0.620 |
Why?
|
| Interleukin-1 | 1 | 2019 | 49 | 0.620 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 33 | 0.610 |
Why?
|
| Mice, Knockout | 6 | 2019 | 311 | 0.600 |
Why?
|
| Cell Proliferation | 4 | 2014 | 184 | 0.580 |
Why?
|
| Bone Marrow Cells | 2 | 2009 | 53 | 0.570 |
Why?
|
| Body Mass Index | 2 | 2020 | 462 | 0.560 |
Why?
|
| Transforming Growth Factor beta | 3 | 2007 | 87 | 0.560 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2015 | 46 | 0.550 |
Why?
|
| Stem Cells | 3 | 2013 | 39 | 0.530 |
Why?
|
| Chemokine CXCL12 | 1 | 2015 | 9 | 0.480 |
Why?
|
| Organogenesis | 1 | 2015 | 2 | 0.470 |
Why?
|
| Cartilage Diseases | 2 | 2008 | 94 | 0.460 |
Why?
|
| Osteoarthritis | 1 | 2019 | 335 | 0.450 |
Why?
|
| Osteoblasts | 1 | 2014 | 57 | 0.420 |
Why?
|
| Osteosarcoma | 1 | 2014 | 41 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 5 | 2015 | 454 | 0.420 |
Why?
|
| Foot Joints | 1 | 2013 | 4 | 0.410 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2012 | 1 | 0.390 |
Why?
|
| Morphogenesis | 2 | 2015 | 8 | 0.390 |
Why?
|
| Growth Plate | 1 | 2012 | 15 | 0.390 |
Why?
|
| Regenerative Medicine | 2 | 2012 | 5 | 0.390 |
Why?
|
| Bone Regeneration | 2 | 2009 | 69 | 0.370 |
Why?
|
| Serum Albumin, Bovine | 1 | 2010 | 5 | 0.330 |
Why?
|
| Genetic Therapy | 1 | 2010 | 86 | 0.330 |
Why?
|
| Humans | 21 | 2020 | 27307 | 0.330 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 18 | 0.320 |
Why?
|
| Adipose Tissue | 3 | 2018 | 76 | 0.320 |
Why?
|
| Proteins | 1 | 2010 | 63 | 0.320 |
Why?
|
| Tibial Fractures | 1 | 2009 | 7 | 0.320 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2014 | 38 | 0.310 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 324 | 0.300 |
Why?
|
| Bone and Bones | 3 | 2018 | 117 | 0.300 |
Why?
|
| Obesity | 3 | 2020 | 309 | 0.290 |
Why?
|
| Neoplasms | 1 | 2010 | 242 | 0.280 |
Why?
|
| Biomarkers | 2 | 2020 | 561 | 0.270 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2005 | 5 | 0.270 |
Why?
|
| Mesoderm | 2 | 2005 | 18 | 0.260 |
Why?
|
| Female | 13 | 2020 | 15334 | 0.260 |
Why?
|
| Chondrogenesis | 1 | 2006 | 32 | 0.250 |
Why?
|
| Apoptosis | 2 | 2004 | 216 | 0.240 |
Why?
|
| Bone Density | 2 | 2020 | 145 | 0.240 |
Why?
|
| Stem Cell Transplantation | 1 | 2005 | 44 | 0.220 |
Why?
|
| Male | 10 | 2020 | 14887 | 0.210 |
Why?
|
| Somatomedins | 1 | 2003 | 4 | 0.210 |
Why?
|
| Cells, Cultured | 4 | 2013 | 527 | 0.210 |
Why?
|
| Rodentia | 1 | 2022 | 7 | 0.200 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2022 | 21 | 0.200 |
Why?
|
| Cartilage, Articular | 3 | 2013 | 419 | 0.200 |
Why?
|
| Stem Cell Niche | 2 | 2013 | 2 | 0.190 |
Why?
|
| Adiponectin | 2 | 2012 | 10 | 0.190 |
Why?
|
| Omentum | 2 | 2012 | 7 | 0.190 |
Why?
|
| Cell Movement | 2 | 2014 | 82 | 0.190 |
Why?
|
| X-Ray Microtomography | 2 | 2012 | 80 | 0.190 |
Why?
|
| Prospective Studies | 4 | 2020 | 1792 | 0.180 |
Why?
|
| Recombinant Proteins | 2 | 2012 | 183 | 0.180 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 67 | 0.170 |
Why?
|
| Osteoclasts | 1 | 2020 | 22 | 0.160 |
Why?
|
| Postoperative Period | 2 | 2019 | 334 | 0.160 |
Why?
|
| Case-Control Studies | 2 | 2019 | 589 | 0.160 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2019 | 4 | 0.160 |
Why?
|
| Bariatric Surgery | 1 | 2020 | 52 | 0.160 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2019 | 20 | 0.160 |
Why?
|
| Aging | 2 | 2019 | 1555 | 0.160 |
Why?
|
| Preoperative Period | 1 | 2019 | 82 | 0.150 |
Why?
|
| Analysis of Variance | 1 | 2019 | 258 | 0.150 |
Why?
|
| Transcription Factors | 2 | 2014 | 169 | 0.150 |
Why?
|
| Embryo, Mammalian | 2 | 2010 | 25 | 0.150 |
Why?
|
| Middle Aged | 8 | 2020 | 9068 | 0.150 |
Why?
|
| Injections, Intra-Articular | 1 | 2019 | 93 | 0.150 |
Why?
|
| Down-Regulation | 1 | 2019 | 109 | 0.150 |
Why?
|
| Up-Regulation | 1 | 2019 | 185 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 32 | 0.140 |
Why?
|
| Phenotype | 1 | 2019 | 313 | 0.140 |
Why?
|
| Comorbidity | 1 | 2019 | 488 | 0.140 |
Why?
|
| Kidney | 1 | 2018 | 152 | 0.140 |
Why?
|
| Treatment Outcome | 2 | 2019 | 3540 | 0.130 |
Why?
|
| Disease Progression | 1 | 2019 | 672 | 0.130 |
Why?
|
| Adult | 6 | 2020 | 7945 | 0.130 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 176 | 0.130 |
Why?
|
| Adipocytes | 2 | 2012 | 22 | 0.120 |
Why?
|
| Cell Separation | 1 | 2015 | 25 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 270 | 0.110 |
Why?
|
| Insulin Resistance | 2 | 2012 | 50 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1807 | 0.110 |
Why?
|
| Sp7 Transcription Factor | 1 | 2014 | 1 | 0.110 |
Why?
|
| Proteasome Inhibitors | 1 | 2014 | 2 | 0.110 |
Why?
|
| Leupeptins | 1 | 2014 | 3 | 0.110 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2014 | 6 | 0.110 |
Why?
|
| Mice, Nude | 1 | 2014 | 25 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2014 | 24 | 0.110 |
Why?
|
| RNA Interference | 1 | 2014 | 42 | 0.110 |
Why?
|
| Osteocalcin | 1 | 2014 | 27 | 0.110 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 103 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 34 | 0.110 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 86 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2020 | 930 | 0.110 |
Why?
|
| Phosphorylation | 1 | 2014 | 147 | 0.110 |
Why?
|
| Models, Biological | 1 | 2015 | 320 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 125 | 0.100 |
Why?
|
| Forelimb | 1 | 2013 | 6 | 0.100 |
Why?
|
| Antigens, Differentiation | 1 | 2013 | 10 | 0.100 |
Why?
|
| Synovial Membrane | 1 | 2013 | 56 | 0.100 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 50 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 225 | 0.100 |
Why?
|
| Subcutaneous Fat | 1 | 2012 | 8 | 0.100 |
Why?
|
| Fibroblasts | 1 | 2012 | 57 | 0.100 |
Why?
|
| Gene Expression | 1 | 2013 | 201 | 0.090 |
Why?
|
| E2F4 Transcription Factor | 1 | 2011 | 2 | 0.090 |
Why?
|
| Leptin | 1 | 2011 | 21 | 0.090 |
Why?
|
| Cell Migration Assays | 1 | 2011 | 1 | 0.090 |
Why?
|
| Retroviridae | 1 | 2011 | 5 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 19 | 0.090 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 40 | 0.090 |
Why?
|
| Transfection | 1 | 2011 | 121 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 2011 | 59 | 0.090 |
Why?
|
| Time Factors | 1 | 2015 | 1444 | 0.090 |
Why?
|
| Pregnancy | 1 | 2012 | 339 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 87 | 0.090 |
Why?
|
| Wound Healing | 1 | 2012 | 159 | 0.090 |
Why?
|
| Osteogenesis | 1 | 2011 | 104 | 0.090 |
Why?
|
| Regeneration | 1 | 2010 | 18 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 155 | 0.090 |
Why?
|
| Cholic Acids | 1 | 2010 | 1 | 0.080 |
Why?
|
| Hindlimb | 1 | 2010 | 15 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 26 | 0.080 |
Why?
|
| Chitosan | 1 | 2010 | 9 | 0.080 |
Why?
|
| Nanoparticles | 1 | 2010 | 11 | 0.080 |
Why?
|
| Biomechanical Phenomena | 1 | 2012 | 643 | 0.080 |
Why?
|
| Cattle | 1 | 2010 | 124 | 0.080 |
Why?
|
| Hypertrophy | 1 | 2009 | 24 | 0.080 |
Why?
|
| Luminescent Proteins | 1 | 2009 | 7 | 0.080 |
Why?
|
| Receptors, CXCR4 | 1 | 2009 | 17 | 0.080 |
Why?
|
| Animals, Genetically Modified | 1 | 2009 | 19 | 0.080 |
Why?
|
| Extremities | 1 | 2007 | 26 | 0.070 |
Why?
|
| Esophageal Neoplasms | 1 | 2004 | 50 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 140 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 275 | 0.050 |
Why?
|
| Cell Line | 1 | 2003 | 292 | 0.050 |
Why?
|
| Gastrectomy | 1 | 2020 | 30 | 0.040 |
Why?
|
| Morbidity | 1 | 2020 | 54 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 216 | 0.040 |
Why?
|
| Bone Development | 1 | 2018 | 32 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2020 | 188 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2012 | 1903 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2012 | 10 | 0.020 |
Why?
|
| Finite Element Analysis | 1 | 2012 | 29 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 17 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 44 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 92 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 279 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 3551 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 317 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 290 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 9120 | 0.020 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2004 | 3 | 0.010 |
Why?
|
| COS Cells | 1 | 2004 | 39 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 82 | 0.010 |
Why?
|